CLINICAL_TRIALS ClinicalTrials.gov record update

A Feasibility Study of "Early" Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory High-Grade Myeloid Neoplasms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02756572
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:24.667661+00:00
Published At: 2021-03-22T00:00:00+00:00
Record Updated At: 2021-11-08
Results Posted At: 2021-03-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Blasts 10 Percent or More of Bone Marrow Nucleated Cells", "Chronic Myelomonocytic Leukemia-2", "High Grade Malignant Neoplasm", "Myelodysplastic Syndrome", "Myelodysplastic Syndrome With Excess Blasts-2", "Myeloid Neoplasm", "Previously Treated Myelodysplastic Syndrome", "Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-11-08"
protocolSection.identificationModule.nctId: "NCT02756572"
protocolSection.identificationModule.officialTitle: "A Feasibility Study of \"Early\" Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory High-Grade Myeloid Neoplasms"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-03-22"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.